Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 8:46 PM ET


Company Overview of iNtRON Biotechnology, Inc.

Company Overview

iNtRON Biotechnology, Inc., a bio new drug company, develops, manufactures, and commercializes bio-medicines targeting infectious diseases. The company offers super bacteria drugs, such as Sal 200 and NPA 200; cancer treating drug delivery media; heme-iron supplements, antibiotic alternative products for animals; and various lab reagents and kits, as well as nucleic acid tests for new flu, VRE super bacteria, food poison, and Al. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea.

#701~704, 505, 903 JungAng Induspia


137, Sagimakgol-ro


Seongnam,  461-804

South Korea

Founded in 1999


82 3 1739 5678


82 3 1739 7246

Key Executives for iNtRON Biotechnology, Inc.

iNtRON Biotechnology, Inc. does not have any Key Executives recorded.

iNtRON Biotechnology, Inc. Key Developments

iNtRON Biotechnology, Inc., Annual General Meeting, Mar 27, 2015

iNtRON Biotechnology, Inc., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: 137 Jungwon-gu, Seongnam, Gyeonggi sagimakgol to sangdaewondong, Central indeoseupiah 503 of the 5th. Agenda: To consider the approval of financial statements.

iNtRON Biotechnology, Inc. Proposes Amendments to Articles of Incorporation

iNtRON Biotechnology, Inc. proposed amendments to Articles of Incorporation to be approved at the EGM to be held on December 24, 2014.

iNtRON Biotechnology, Inc., Special/Extraordinary Shareholders Meeting, Dec 24, 2014

iNtRON Biotechnology, Inc., Special/Extraordinary Shareholders Meeting, Dec 24, 2014., at 10:00 Korea Standard Time. Location: Headquarters conference room. Agenda: To approve some changes to the Articles of Incorporation Articles; and to approve the Audit Senior Articles.

Similar Private Companies By Industry

Company Name Region
Neurobiosys Asia
BiocurePharm, Inc. Asia
AptaBio Therapeutics Inc. Asia
Anterogen Co., Ltd. Asia
SNP Genetics Inc. Asia

Recent Private Companies Transactions

Private Placement
July 20, 2015
Shandong Baolai-Leelai Bio-Industrial Group Ltd.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact iNtRON Biotechnology, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at